UB Paderborn / Katalog / Suche / in CDI

Whole genome sequencing of Trypanosoma cruzi field isolates reveals extensive genomic variability and complex aneuploidy patterns within TcII DTU

BMC genomics, 2018-11, Vol.19 (1), p.816-816, Article 816

2018

Volltextzugriff (PDF)

Co‐infection with distinct Trypanosoma cruzi strains induces an activated immune response in human monocytes

Parasite immunology, 2019-11, Vol.41 (11), p.e12668-n/a

2019

Volltextzugriff (PDF)

PCR Assay for Monitoring Trypanosoma cruzi Parasitemia in Childhood after Specific Chemotherapy

Journal of Clinical Microbiology, 2003-11, Vol.41 (11), p.5066-5070

2003

Volltextzugriff (PDF)

Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study

Memórias do Instituto Oswaldo Cruz, 2010-09, Vol.105 (6), p.834-837

2010

Volltextzugriff (PDF)

Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

Journal of Clinical Microbiology, 2004-02, Vol.42 (2), p.707-712

2004

Volltextzugriff (PDF)

Trypanosoma cruzi Recombinant Complement Regulatory Protein: a Novel Antigen for Use in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Chagas' Disease

Journal of Clinical Microbiology, 2002-10, Vol.40 (10), p.3735-3740

2002

Volltextzugriff (PDF)

Trypanosoma cruzi : blood parasitism kinetics and their correlation with heart parasitism intensity during long-term infection of Beagle dogs

Memórias do Instituto Oswaldo Cruz, 2008-09, Vol.103 (6), p.528-534

2008

Volltextzugriff (PDF)

Immunological imbalance between IFN-γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Memórias do Instituto Oswaldo Cruz, 2009-02, Vol.104 (1), p.100-105

2009

Volltextzugriff (PDF)

Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi

PLoS neglected tropical diseases, 2015, Vol.9 (7), p.e0003816-e0003816

2015

Volltextzugriff (PDF)

Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-γ, TNF-α, and low IL-10 production during the acute infection phase

Veterinary immunology and immunopathology, 2009-07, Vol.130 (1), p.43-52

2009

Volltextzugriff (PDF)

Naturally Leishmania infantum-infected dogs display an overall impairment of chemokine and chemokine receptor expression during visceral leishmaniasis

Veterinary immunology and immunopathology, 2013-06, Vol.153 (3-4), p.202-208

2013

Volltextzugriff (PDF)

Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil

International journal for parasitology, 2009-07, Vol.39 (9), p.963-973

2009

Volltextzugriff (PDF)

IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains

Veterinary immunology and immunopathology, 2008-07, Vol.124 (1), p.163-168

2008

Volltextzugriff (PDF)

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs

Memórias do Instituto Oswaldo Cruz, 2007-05, Vol.102 (2), p.141-147

2007

Volltextzugriff (PDF)

Increased type 1 chemokine expression in experimental Chagas disease correlates with cardiac pathology in Beagle dogs

Veterinary immunology and immunopathology, 2010-11, Vol.138 (1), p.106-113

2010

Volltextzugriff (PDF)

Immunological imbalance between IFN-³ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Memórias do Instituto Oswaldo Cruz, 2009-02, Vol.104 (1), p.100-105

2009

Volltextzugriff (PDF)

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

Memórias do Instituto Oswaldo Cruz, 2010-11, Vol.105 (7), p.918-924

2010

Volltextzugriff (PDF)

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagledogs

Memórias do Instituto Oswaldo Cruz, 2007-03, Vol.102 (2), p.141-147

2007

Volltextzugriff (PDF)

Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi: e0003816

PLoS neglected tropical diseases, 2015-07, Vol.9 (7)

2015

Volltextzugriff (PDF)

Differential transcription profiles in Trypanosoma cruzi associated with clinical forms of Chagas disease: Maxicircle NADH dehydrogenase subunit 7 gene truncation in asymptomatic patient isolates

Molecular and biochemical parasitology, 2006-12, Vol.150 (2), p.236-248

2006

Volltextzugriff (PDF)

Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy

Parasite immunology, 1996-11, Vol.18 (11), p.579-585

1996

Volltextzugriff (PDF)

Chagas Disease: Criteria of Cure and Prognosis

Memórias do Instituto Oswaldo Cruz, 1999-01, Vol.94 (s1), p.357-362

1999

Volltextzugriff (PDF)

Difference in susceptibility to lysis between clones of the Y strain of Trypanosoma cruzi

Memórias do Instituto Oswaldo Cruz, 1993-12, Vol.88 (4), p.529-534

1993

Volltextzugriff (PDF)

Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein

Protein expression and purification, 2003, Vol.27 (1), p.19-26

2003

Volltextzugriff (PDF)

Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease

Revista da Sociedade Brasileira de Medicina Tropical, 2006, Vol.39 Suppl 3, p.107-109

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Whole genome sequencing of Trypanosoma cruzi field isolates reveals extensive genomic variability and complex aneuploidy patterns within TcII DTU

Co‐infection with distinct Trypanosoma cruzi strains induces an activated immune response in human monocytes

PCR Assay for Monitoring Trypanosoma cruzi Parasitemia in Childhood after Specific Chemotherapy

Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study

Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

Trypanosoma cruzi Recombinant Complement Regulatory Protein: a Novel Antigen for Use in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Chagas' Disease

Trypanosoma cruzi : blood parasitism kinetics and their correlation with heart parasitism intensity during long-term infection of Beagle dogs

Immunological imbalance between IFN-γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi

Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-γ, TNF-α, and low IL-10 production during the acute infection phase

Naturally Leishmania infantum-infected dogs display an overall impairment of chemokine and chemokine receptor expression during visceral leishmaniasis

Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil

IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs

Increased type 1 chemokine expression in experimental Chagas disease correlates with cardiac pathology in Beagle dogs

Immunological imbalance between IFN-³ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagledogs

Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi: e0003816

Differential transcription profiles in Trypanosoma cruzi associated with clinical forms of Chagas disease: Maxicircle NADH dehydrogenase subunit 7 gene truncation in asymptomatic patient isolates

Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy

Chagas Disease: Criteria of Cure and Prognosis

Difference in susceptibility to lysis between clones of the Y strain of Trypanosoma cruzi

Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein

Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease

Suchergebnisse filtern